CAMP4 THERAPEUTICS CORPORATION
NASDAQ: CAMP (CAMP4 THERAPEUTICS CORPORATION)
Last update: 12 hours ago4.00
0.16 (4.17%)
| Previous Close | 3.84 |
| Volume | 367,956 |
| Price / Sales | 43.60 |
| Price / Book | 9.11 |
| 52 Weeks Range |
| Operating Margin (TTM) | -1,526.81% |
| Diluted EPS (TTM) | -2.57 |
| Total Debt/Equity (MRQ) | 15.44% |
| Current Ratio (MRQ) | 8.02 |
| Operating Cash Flow (TTM) | -48.70 M |
| Levered Free Cash Flow (TTM) | -29.66 M |
| Return on Assets (TTM) | -71.88% |
| Return on Equity (TTM) | -115.06% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | CAMP4 THERAPEUTICS CORPORATION | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | -0.83 |
|
Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. The company focuses on genetic diseases of the central nervous system and liver. Its pipeline products include CMP-CPS-001 and CMP-SYNGAP. The company operates as a single operating segment, R&D, which engages in the development of a new class of RNA-based therapeutics to treat a broad range of genetic diseases. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 35.41% |
| % Held by Institutions | 56.56% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Harbourvest Partners Llc | 30 Jun 2026 | 1,271,948 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |